This company listing is no longer active
Liminal BioSciences Management
Management criteria checks 2/4
Key information
Bruce Pritchard
Chief executive officer
CA$1.1m
Total compensation
CEO salary percentage | 54.8% |
CEO tenure | 2.5yrs |
CEO ownership | 0.04% |
Management average tenure | 2.5yrs |
Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2022 | CA$1m | CA$618k | -CA$29m |
Sep 30 2022 | n/a | n/a | -CA$31m |
Jun 30 2022 | n/a | n/a | -CA$35m |
Mar 31 2022 | n/a | n/a | -CA$42m |
Dec 31 2021 | CA$1m | CA$591k | -CA$44m |
Sep 30 2021 | n/a | n/a | -CA$48m |
Jun 30 2021 | n/a | n/a | -CA$49m |
Mar 31 2021 | n/a | n/a | -CA$35m |
Dec 31 2020 | CA$2m | CA$556k | -CA$48m |
Sep 30 2020 | n/a | n/a | -CA$75m |
Jun 30 2020 | n/a | n/a | -CA$94m |
Mar 31 2020 | n/a | n/a | -CA$232m |
Dec 31 2019 | CA$5m | CA$563k | -CA$150m |
Sep 30 2019 | n/a | n/a | -CA$299m |
Jun 30 2019 | n/a | n/a | -CA$298m |
Mar 31 2019 | n/a | n/a | -CA$194m |
Dec 31 2018 | CA$1m | CA$575k | -CA$197m |
Sep 30 2018 | n/a | n/a | -CA$131m |
Jun 30 2018 | n/a | n/a | -CA$118m |
Mar 31 2018 | n/a | n/a | -CA$115m |
Dec 31 2017 | CA$3m | CA$526k | -CA$112m |
Sep 30 2017 | n/a | n/a | -CA$109m |
Jun 30 2017 | n/a | n/a | -CA$119m |
Mar 31 2017 | n/a | n/a | -CA$112m |
Dec 31 2016 | CA$2m | CA$531k | -CA$101m |
Compensation vs Market: Bruce's total compensation ($USD832.66K) is above average for companies of similar size in the German market ($USD435.93K).
Compensation vs Earnings: Bruce's compensation has increased whilst the company is unprofitable.
CEO
Bruce Pritchard (48 yo)
2.5yrs
Tenure
CA$1,127,987
Compensation
Mr. Bruce Pritchard, BA, CA, FioD, served as Principal Financial Officer at Liminal BioSciences Inc. since September 3, 2021. Mr. Pritchard served as Chief Operating Officer of Small Molecule Therapeutics...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 2.5yrs | CA$1.13m | 0.043% CA$ 5.1k | |
President | 2.5yrs | CA$866.09k | 0.010% CA$ 1.2k | |
Interim Chief Scientific Officer & Non-Independent Director | less than a year | CA$428.33k | no data | |
Corporate Secretary & General Counsel | 3.7yrs | CA$637.35k | no data | |
Chief Financial Officer | 1.2yrs | no data | no data | |
Manager of Investor Relations & Communications | no data | no data | no data | |
President of Prometic Bioseparations Ltd | no data | CA$294.54k | no data |
2.5yrs
Average Tenure
48yo
Average Age
Experienced Management: PJ2's management team is considered experienced (2.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Interim Chief Scientific Officer & Non-Independent Director | 4yrs | CA$428.33k | no data | |
Independent Chair of the Board | 2.7yrs | CA$178.00k | no data | |
Lead Independent Director | 9yrs | CA$167.58k | 0.069% CA$ 8.2k | |
Non-Independent Director | 2.7yrs | no data | no data | |
Board Observer | 4.1yrs | no data | no data | |
Independent Director | 4yrs | CA$132.23k | no data | |
Independent Director | 4yrs | CA$120.67k | 0.029% CA$ 3.4k |
4.0yrs
Average Tenure
58yo
Average Age
Experienced Board: PJ2's board of directors are considered experienced (4 years average tenure).